{{Rsnum
|rsid=488248
|Chromosome=13
|position=105944370
|Orientation=plus
|GMAF=0.2713
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.8 | 41.6 | 49.6
| HCB | 2.2 | 24.1 | 73.7
| JPT | 0.9 | 18.6 | 80.5
| YRI | 17.0 | 44.2 | 38.8
| ASW | 8.8 | 63.2 | 28.1
| CHB | 2.2 | 24.1 | 73.7
| CHD | 5.5 | 23.9 | 70.6
| GIH | 3.0 | 16.8 | 80.2
| LWK | 23.6 | 43.6 | 32.7
| MEX | 1.7 | 27.6 | 70.7
| MKK | 19.9 | 50.6 | 29.5
| TSI | 5.9 | 31.4 | 62.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=3E-6
  |OR=2.90
  |ORtxt=[1.802-4.665]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}